Sofmox-DF Eye Drops

Listing ID #3957631

Moxifloxacin :

• Broad spectrum bactericidal antibiotic
• Enhanced activity and excellent coverage against common
• ocular pathogens like I. pneumoniae, Haemophilus influenzae,
• 1 and methicillin sus-ceptibile staphylococci
• 1 2–4 times lower MIC90s versus ciprofloxacin

Difluprednate :

• First steroid approved by FDA specifically for
• pain management
• 2 Most potent ophthalmic steroid
• 56 times stronger glucocorticoid binding
• 2 affinity than prednisolone

Inflammation and pain associated with ocular surgery. Endogenous anterior uveitis

Composition :

• Mocifloxacin HCI - IP             
• eq.  to Mocifloxacin - 0.5%w/v
• Difluprednate - 0.05%w/v
• Sorbiv acid (as preservetive) IP - 0.1%w/v
• Sterile Aqueous base q.s

Warning

• If irritation persists or increases discontinue the use & consult your doctor.
• Do not touch the nozzle tip to any surface since this may contaminate.
• If the particulate matter is found, reject the vial.
• Use the solution within one month after opening the  containor

Direction for use

• Tighten the cap on the nozzle by turning it as shown the spike in the cap will pierce the ti of the vial.
• The vial is ready for use when the cap is opened